References to these types of products in the USP are not product-specific monographs
Ingredients Bulking agent cellulose, L-glutathione reduced, carriers calcium phosphate and cross-linked sodium carboxymethyl cellulose, lactose monohydrate, pomegranate peel extract (Punica L.), superoxide dismutase, maltodextrin, milk thistle seed extract (Silybum marianum L.), L-cysteine, anti-caking agents magnesium salts of fatty acids and silicon dioxide, glazing agent (neutral methacrylate copolymer, talc, propylene glycol, colorant carmine)
Administration Routes and Techniques Most GLP-1 agonists are administered via subcutaneous injection, meaning the medication is injected into the fatty tissue just under the skin
Organic sourcing ensures that no synthetic pesticides or fertilizers were used in the cultivation process
Coverage terms differ from those for Rybelsus, which is approved only for type 2 diabetes